WallStreetZenWallStreetZen

NASDAQ: IMRX
Immuneering Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immuneering earnings were -$56.0M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest IMRX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$11.6M, down 22.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IMRX reported annual earnings of -$56.0M, with -8.2% growth. The next IMRX earnings date is May 12, 2026.

IMRX earnings history

Current Revenue
$0.0
Current Earnings
-$56.0M
Current Profit Margin
0%

IMRX Return on Equity

Current Company
-43.3%
Current Industry
-31.4%
Current Market
28.9%
IMRX's Return on Equity (-43.3%)... subscribe to Premium to read more.
High Return on Equity Performance

IMRX Return on Assets

Current Company
-39.7%
Current Industry
-9.6%
IMRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMRX announces earnings.

IMRX Return on Capital Employed

Current Company
-25.25%
Current Industry
-3.7%
IMRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMRX-$55.33M-$56.02MN/A-$1.27
OVID-$15.95M-$17.41MN/A-$0.23
XFOR-$66.35M-$79.20MN/A-$1.87
BCYC-$212.18M-$218.96MN/A-$3.16
CABA-$148.84M-$167.86MN/A-$2.10
View Top Biotech Stocks

IMRX earnings dates

Next earnings date
May 12, 2026

Immuneering Earnings Reports & History FAQ

What were Immuneering's earnings last quarter?

On IMRX's earnings call on Invalid Date, Immuneering (NASDAQ: IMRX) reported Q4 2025 earnings per share (EPS) of -$0.07, up 88.14% year over year. Total IMRX earnings for the quarter were -$11.58 million. In the same quarter last year, Immuneering's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Immuneering stock.

When does Immuneering report earnings?

The next IMRX earnings date is Invalid Date. Add IMRX to your watchlist to be reminded of Immuneering's next earnings date.

Is Immuneering profitable or losing money?

As of the last Immuneering earnings report, Immuneering is currently losing money. Immuneering's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$56.02 million, a 8.21% decrease year over year.

What was IMRX's earnings growth in the past year?

As of Immuneering's earnings date in Invalid Date, Immuneering's earnings has grown year over year. IMRX earnings in the past year totalled -$56.02 million.

What are Immuneering's earnings expectations?

The current EPS estimate for Immuneering's earnings report in Invalid Date is -$0.35.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.